AbbVie has announced the appointment of David Manifold as Business Unit Director of Immunology for Australia and New Zealand and Country Head for New Zealand, succeeding Bronwen Marshall, who has been promoted to Commercial Director, Intercontinental, Neuroscience.
AbbVie appoints David Manifold to lead Immunology ANZ and New Zealand operations
October 28, 2025 Latest NewsBioPharmaBioPharmaDispatch Executive
Latest Video
New Stories
-
Australians with chronic disease call for stronger investment in PBS
October 29, 2025 - - Latest News -
Australia launches first clinical and commercial-scale viral vector manufacturing facility
October 28, 2025 - - Latest News -
Myrio Therapeutics partners with leading US research institutions to advance T cell immunotherapies for solid tumours
October 28, 2025 - - Australian Biotech -
MTPConnect signs cooperation agreement with Saudi Ministry of Health to boost life sciences collaboration
October 28, 2025 - - Australian Biotech -
ObvioHealth partners with Vaxxas to advance needle-free vaccination through digital clinical trials
October 28, 2025 - - Australian Biotech -
AbbVie appoints David Manifold to lead Immunology ANZ and New Zealand operations
October 28, 2025 - - Latest News -
Australians want better access to medical technology, and a clearer pathway to get there
October 28, 2025 -
